WCD: Ixekizumab beats etanercept for psoriatic itch

VANCOUVER, B.C. – Ixekizumab-treated patients with plaque psoriasis reported markedly faster and larger improvements in itch severity than those on high-dose etanercept or placebo in a large head-to-head phase III randomized trial. Ixekizumab is an investigational humanized IgG4 monoclonal...googletag.display('div-gpt-ad-cta');
Source: Skin and Allergy News - Category: Dermatology Tags: SAN Conference News RHEUM Conference News SAN Clinical News SAN News SAN Psoriasis RHEUM News RHEUM Spondyloarthropathies RHEUM Psoriatic arthritis Source Type: news